Patent ID: 8802666

Claim:
A method of treating viral pathologies or infections in a patient in need thereof, comprising the step of administering to said patient a therapeutically effective amount of a compound of formula (I): wherein: n is 0, 1 or 2; A is CH or N, or A is C and form, together with R 1 , R 2 and CO, a heterocyclyl group comprising from 5 to 20 atoms, possibly substituted; X is CO, SO 2 or CS, R 1 is chosen from the group consisting of: H, alkyl groups, and aralkyl groups, said alkyl or aralkyl groups being possibly substituted, R 2 is a group of formula NR 3 R 4 or OR 5 , wherein: R 3 and R 4 being each independently chosen from: H, OR a , alkyl groups, aralkyl groups, and aryl groups, R a being chosen from the group consisting of: H, alkyl groups, aryl groups, and aralkyl groups; wherein R 3 and R 4 may form, together with the nitrogen atom carrying them, a heterocyclyl group comprising from 5 to 20 atoms, possibly substituted, R 5 is chosen from: alkyl groups, aryl groups, and aralkyl groups, wherein R 5 may form, together with the oxygen atom carrying it, a heterocyclyl group from 5 to 20 atoms, possibly substituted, R 6 is H or an alkyl group, or may form together with R 2 a heterocyclyl group from 20 to 30 atoms, or may form together with R 1 a heterocyclyl group from 10 to 30 atoms, R 7 is chosen from the group consisting of: aryl groups, heteroaryl groups, —NHPh, heterocyclyl groups, and alkyl groups; wherein when R 7 is aryl, heteroaryl or heterocyclyl, it is substituted by at least one NH 2 group, wherein, when A is N, R 1 and R 2 may form, together with A and CO, a heterocyclyl group comprising from 5 to 20 atoms, possibly substituted, or its pharmaceutically acceptable salts, hydrates or hydrated salts or its polymorphic crystalline structures, racemates, diastereomers or enantiomers.